$KARX
Karbon-X Corp. Stock $karx

$karx Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000147793224005717 Filed on September 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$127.4K		$412.1K
YoY Change	3290.87%		4090.55%
Cost Of Revenue	$94.10K		$356.1K
YoY Change	17039.89%		34641.76%
Gross Profit	$33.33K		$55.95K
YoY Change	938.67%		535.26%
Gross Profit Margin	26.16%		13.58%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$542.00		$2.194K
YoY Change	-2.52%		79.98%
% of Gross Profit	1.63%		3.92%
Operating Expenses	$825.7K		$1.603M
YoY Change	153.69%		-19.45%
Operating Profit	-$792.4K		-$1.547M
YoY Change	145.87%		-21.91%
Interest Expense			$35.86K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$12.41K		-$5.750K
YoY Change	-55.3%		-16.12%
Pretax Income	-$804.8K		-$2.745M
YoY Change	129.91%		38.07%
Income Tax
% Of Pretax Income
Net Earnings	-$804.8K		-$2.745M
YoY Change	129.91%		37.43%
Net Earnings / Revenue	-631.54%		-666.07%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	83.41M shares	78.66M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$2.675M
YoY Change		1193.59%
Cash & Equivalents	$2.299M	$2.675M
Short-Term Investments		$0.00
Other Short-Term Assets		$0.00
YoY Change		-100.0%
Inventory	$362.9K	$316.7K
Prepaid Expenses	$9.247K	$1.000K
Receivables
Other Receivables
Total Short-Term Assets	$2.377M	$2.797M
YoY Change	124.99%	795.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.446K	$6.918K
YoY Change	-25.09%	-24.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$2.564M
YoY Change		69.31%
Other Assets
YoY Change
Total Long-Term Assets	$911.7K	$1.174M
YoY Change	-71.58%	-46.71%
TOTAL ASSETS
Total Short-Term Assets	$2.377M	$2.797M
Total Long-Term Assets	$911.7K	$1.174M
Total Assets	$3.288M	$3.971M
YoY Change	-22.89%	57.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$124.0K	$127.2K
YoY Change	314.61%	82.44%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$36.50K
YoY Change		-63.5%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$139.0K	$839.8K
YoY Change	-48.93%	331.8%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities		$418.9K
YoY Change		655.86%
Total Long-Term Liabilities		$418.9K
YoY Change		655.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$139.0K	$839.8K
Total Long-Term Liabilities		$418.9K
Total Liabilities	$139.0K	$1.142M
YoY Change	-56.83%	357.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.742M	-$4.937M
YoY Change	125.88%	125.23%
Common Stock	$83.42K	$82.18K
YoY Change	6.19%	13.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.149M	$2.828M
YoY Change
Total Liabilities & Shareholders Equity	$3.288M	$3.971M
YoY Change	-22.89%	57.87%

Cashflow Statement

Concept	2024 Q3	2024
OPERATING ACTIVITIES
Net Income	-$804.8K	-$2.745M
YoY Change	129.91%	37.43%
Depreciation, Depletion And Amortization	$542.00	$2.194K
YoY Change	-2.52%	79.98%
Cash From Operating Activities	-$1.460M	-$1.098M
YoY Change	709.94%	-26.06%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$802.4K
YoY Change	-100.0%	6.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$4.322M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.056M	$4.358M
YoY Change	-32.12%	122.83%
NET CHANGE
Cash From Operating Activities	-$1.460M	-$1.098M
Cash From Investing Activities	$0.00	-$802.4K
Cash From Financing Activities	$1.056M	$4.358M
Net Change In Cash	-$376.6K	$2.469M
YoY Change	-149.06%	-1012.53%
FREE CASH FLOW
Cash From Operating Activities	-$1.460M	-$1.098M
Capital Expenditures		$0.00
Free Cash Flow		-$1.098M
YoY Change		-26.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001729637
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73540000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82174750	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	0
CY2023	karx	Warranr Expiration Period WarranrExpirationPeriod	P2Y
CY2024	karx	Warranr Expiration Period WarranrExpirationPeriod	P2Y
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-05-31
CY2024	dei	Entity File Number EntityFileNumber	000-56288
CY2024	dei	Entity Registrant Name EntityRegistrantName	Karbon-X Corp.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-2882342
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	510 5th ST SW
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 910
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Calgary
CY2024	dei	Entity Address Country EntityAddressCountry	CA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	T2P 3S2
CY2024	dei	City Area Code CityAreaCode	844
CY2024	dei	Local Phone Number LocalPhoneNumber	462-3637
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	83413639	shares
CY2024	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC
CY2024	dei	Auditor Firm AuditorFirmId	5525
CY2024	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2675400	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	206820	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	113074	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	7210	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	45586	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	59767	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	2796684	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	312173	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6918	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9116	usd
CY2024Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	521372	usd
CY2023Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	522771	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	316519	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	68307	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	316738	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	80750	usd
CY2024Q2	us-gaap	Investments Investments	0	usd
CY2023Q2	us-gaap	Investments Investments	1514483	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	12351	usd
CY2023Q2	us-gaap	Security Deposit SecurityDeposit	7515	usd
CY2024Q2	us-gaap	Assets Assets	3970582	usd
CY2023Q2	us-gaap	Assets Assets	2515115	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	127219	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	69732	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	21945	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14688	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	36500	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	100000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	630000	usd
CY2023Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	0	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	24103	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10061	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	839769	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	194481	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	302557	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	55415	usd
CY2024Q2	us-gaap	Liabilities Liabilities	1142325	usd
CY2023Q2	us-gaap	Liabilities Liabilities	249896	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82174750	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73540000	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	82176	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	72579	usd
CY2024Q2	karx	Shares To Be Issued SharesToBeIssued	0	usd
CY2023Q2	karx	Shares To Be Issued SharesToBeIssued	1750000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7675826	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2638532	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4937342	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2192106	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7597	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3786	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2828257	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2265219	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3970582	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2515115	usd
CY2024	us-gaap	Revenues Revenues	412057	usd
CY2023	us-gaap	Revenues Revenues	9833	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	356103	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1025	usd
CY2024	us-gaap	Gross Profit GrossProfit	55954	usd
CY2023	us-gaap	Gross Profit GrossProfit	8808	usd
CY2024	us-gaap	Marketing Expense MarketingExpense	176476	usd
CY2023	us-gaap	Marketing Expense MarketingExpense	1250959	usd
CY2024	us-gaap	Salaries And Wages SalariesAndWages	754286	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	211588	usd
CY2024	us-gaap	Interest Expense InterestExpense	35856	usd
CY2023	us-gaap	Interest Expense InterestExpense	0	usd
CY2024	us-gaap	Professional Fees ProfessionalFees	252064	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	255764	usd
CY2024	us-gaap	Other Expenses OtherExpenses	384215	usd
CY2023	us-gaap	Other Expenses OtherExpenses	271519	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	1602897	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1989830	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-1546943	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1981022	usd
CY2024	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1191890	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5750	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6855	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2744583	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1987877	usd
CY2024	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2744583	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1987877	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	11383	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-9258	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2733200	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1997135	usd
CY2024	karx	Weighted Average Basic And Diluted Shares Outstanding WeightedAverageBasicAndDilutedSharesOutstanding	77165230	shares
CY2023	karx	Weighted Average Basic And Diluted Shares Outstanding WeightedAverageBasicAndDilutedSharesOutstanding	69742784	shares
CY2024	karx	Earnings Per Share Basic And Fully Diluted EarningsPerShareBasicAndFullyDiluted	-0.04
CY2023	karx	Earnings Per Share Basic And Fully Diluted EarningsPerShareBasicAndFullyDiluted	-0.03
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	637870	usd
CY2023	karx	Shares To Be Issued For Investment SharesToBeIssuedForInvestment	1125000	usd
CY2023	karx	Shares To Be Issued For Stock Compensation SharesToBeIssuedForStockCompensation	625000	usd
CY2023	karx	Issuance Of Shares And Warrants For Cash Amount IssuanceOfSharesAndWarrantsForCashAmount	1855969	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	9258	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1987877	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2265219	usd
CY2024	karx	Shares To Be Issued For Investment SharesToBeIssuedForInvestment	375000	usd
CY2024	karx	Shares To Issued As Stock Compensation Amount SharesToIssuedAsStockCompensationAmount	0	usd
CY2024	karx	Issuance Of Shares For Cash And Warrants Net Amount IssuanceOfSharesForCashAndWarrantsNetAmount	4325724	usd
CY2024	karx	Conversion Of Loan To Shares Amount ConversionOfLoanToSharesAmount	100000	usd
CY2024	karx	Offering Operating Expenses OfferingOperatingExpenses	-3833	usd
CY2024	karx	Write Off Of Investment In Silviculture WriteOffOfInvestmentInSilviculture	-1500000	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	10730	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2744583	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2828257	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-2744583	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1987877	usd
CY2024	us-gaap	Depreciation Depreciation	2194	usd
CY2023	us-gaap	Depreciation Depreciation	1219	usd
CY2024	karx	Gain Loss On Investment GainLossOnInvestment	-1191890	usd
CY2023	karx	Gain Loss On Investment GainLossOnInvestment	-8039	usd
CY2024	karx	Lease Right Of Use Asset Amortization Expense LeaseRightOfUseAssetAmortizationExpense	-246996	usd
CY2023	karx	Lease Right Of Use Asset Amortization Expense LeaseRightOfUseAssetAmortizationExpense	3177	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	625000	usd
CY2024	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-38376	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	34777	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	113074	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	32448	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	38979	usd
CY2024	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	630000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2024	us-gaap	Increase Decrease In Trading Liabilities IncreaseDecreaseInTradingLiabilities	39082	usd
CY2023	us-gaap	Increase Decrease In Trading Liabilities IncreaseDecreaseInTradingLiabilities	7084	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	235988	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	80750	usd
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-58767	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	59465	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	254587	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1205	usd
CY2024	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-4837	usd
CY2023	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-6903	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1098134	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1485069	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7058	usd
CY2024	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	802407	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	397523	usd
CY2024	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	345994	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-802407	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-750575	usd
CY2024	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	36500	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	100000	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4321891	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1855969	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4358391	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1955969	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10730	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9155	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2468580	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-270520	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	206820	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	477339	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2675400	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	206820	usd
CY2024	karx	Capitalization Of Right Of Use Asset CapitalizationOfRightOfUseAsset	0	usd
CY2023	karx	Capitalization Of Right Of Use Asset CapitalizationOfRightOfUseAsset	-71425	usd
CY2024	karx	Capitalization Of Lease Liability CapitalizationOfLeaseLiability	0	usd
CY2023	karx	Capitalization Of Lease Liability CapitalizationOfLeaseLiability	-68920	usd
CY2024	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	0	usd
CY2023	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	1219	usd
CY2024	karx	Loss On Investment LossOnInvestment	0	usd
CY2023	karx	Loss On Investment LossOnInvestment	8039	usd
CY2024	karx	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	0	usd
CY2023	karx	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	3177	usd
CY2024	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	0	usd
CY2023	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	625000	usd
CY2024	karx	Shares To Be Issued For The Silviculture Investment SharesToBeIssuedForTheSilvicultureInvestment	0	usd
CY2023	karx	Shares To Be Issued For The Silviculture Investment SharesToBeIssuedForTheSilvicultureInvestment	1125000	usd
CY2024	karx	Write Off Of Investment In Silviculture Investment WriteOffOfInvestmentInSilvicultureInvestment	-1500000	usd
CY2024	karx	Shares To Be Issued As Stock Based Compensation SharesToBeIssuedAsStockBasedCompensation	0	usd
CY2023	karx	Shares To Be Issued As Stock Based Compensation SharesToBeIssuedAsStockBasedCompensation	625000	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	karx	Issued And Outstanding Shares Of Common Stock Converted Exchange Ratio Description IssuedAndOutstandingSharesOfCommonStockConvertedExchangeRatioDescription	20,000-for-1
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2024	us-gaap	Other Operating Income OtherOperatingIncome	4937342	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. </p>
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	2564203	usd
CY2024Q2	karx	Accumulated Value Of Shares To Be Issued AccumulatedValueOfSharesToBeIssued	1500000	usd
CY2024	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	1064203	usd
CY2024Q2	karx	Prepaid Inventory Current PrepaidInventoryCurrent	0	usd
CY2023Q2	karx	Prepaid Inventory Current PrepaidInventoryCurrent	59767	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1000	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	0	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	59767	usd
CY2024Q2	karx	Carbon Credit Inventory Amount CarbonCreditInventoryAmount	316738	usd
CY2023Q2	karx	Carbon Credit Inventory Amount CarbonCreditInventoryAmount	80750	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	316738	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	80750	usd
CY2024Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	6589	usd
CY2023Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	6607	usd
CY2024Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	3695	usd
CY2023Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	3705	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10284	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10312	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3366	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1196	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6918	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9116	usd
CY2024	us-gaap	Depreciation Depreciation	2194	usd
CY2023	us-gaap	Depreciation Depreciation	1219	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	100000	usd
CY2023Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	200000	shares
CY2023Q2	karx	Conversion Of Loan Per Shares ConversionOfLoanPerShares	0.50
CY2024Q1	karx	Issued Additional Common Stock IssuedAdditionalCommonStock	61111	shares
CY2024Q2	karx	Warrants Issued WarrantsIssued	10400	shares
CY2024	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.50
CY2024	karx	Value Of Warrants ValueOfWarrants	2236	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	830000	shares
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2990000	shares
CY2024	karx	Warrants Average Price WarrantsAveragePrice	0.75
CY2023Q2	karx	Warrants Issued WarrantsIssued	720000	shares
CY2023	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.75
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	180000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4140000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2024	karx	Weighted Average Remaining Contractual Life In Years Beginning Balance WeightedAverageRemainingContractualLifeInYearsBeginningBalance	P0Y9M29D
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2990000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.75
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10400	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.75
CY2024	karx	Weighted Average Remaining Contractual Life In Years Granted WeightedAverageRemainingContractualLifeInYearsGranted	P1Y1M17D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	830000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.75
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	330400	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.63
CY2024	karx	Weighted Average Remaining Contractual Life In Years Ending Balance WeightedAverageRemainingContractualLifeInYearsEndingBalance	P0Y7M17D
CY2023	karx	Share Exchange Agreement ShareExchangeAgreement	0.80	pure
CY2023	karx	Share Exchange Agreement Value ShareExchangeAgreementValue	7250000	usd
CY2024Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	521372	usd
CY2023Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	522771	usd
CY2024	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	34511	usd
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	15992	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	29573	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	109477	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	109477	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	114685	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	119893	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	135529	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	618633	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	160065	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	458568	usd
CY2024Q2	karx	Operating Lease Liability Other Current OperatingLeaseLiabilityOtherCurrent	37522	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	418895	usd
CY2024	karx	Operating Lease Weighted Average Discounts Rate Percent OperatingLeaseWeightedAverageDiscountsRatePercent	0.1025	pure
CY2024	karx	Weighted Average Remaining Lease Term Years WeightedAverageRemainingLeaseTermYears	P3Y2M1D

Files In Submission

Name	View Source	Status
0001477932-24-005717-index-headers.html	Edgar Link	pending
0001477932-24-005717-index.html	Edgar Link	pending
0001477932-24-005717.txt	Edgar Link	pending
0001477932-24-005717-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
karx-20240531.xsd	Edgar Link	pending
karx_10k.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
karx-20240531_cal.xml	Edgar Link	unprocessable
karx-20240531_def.xml	Edgar Link	unprocessable
karx-20240531_lab.xml	Edgar Link	unprocessable
karx-20240531_pre.xml	Edgar Link	unprocessable
karx_10kimg2.jpg	Edgar Link	pending
karx_10kimg3.jpg	Edgar Link	pending
karx_ex21.htm	Edgar Link	pending
karx_ex311.htm	Edgar Link	pending
karx_ex312.htm	Edgar Link	pending
karx_ex321.htm	Edgar Link	pending
karx_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
karx_10k_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KARX
Karbon-X Corp. Stock $karx

2024 Q3 Form 10-K Financial Statement

#000147793224005717 Filed on September 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KARX Karbon-X Corp. Stock $karx

2024 Q3 Form 10-K Financial Statement

#000147793224005717 Filed on September 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KARX
Karbon-X Corp. Stock $karx